Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

IMPORTANCE: Recent SARS-CoV-2 Omicron variant sublineages, including BA.4 and BA.5, may be associated with greater immune evasion and less protection against COVID-19 after vaccination. OBJECTIVES: To evaluate the estimated vaccine effectiveness (VE) of 2, 3, or 4 doses of COVID-19 mRNA vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Link-Gelles, Ruth, Levy, Matthew E., Natarajan, Karthik, Reese, Sarah E., Naleway, Allison L., Grannis, Shaun J., Klein, Nicola P., DeSilva, Malini B., Ong, Toan C., Gaglani, Manjusha, Hartmann, Emily, Dickerson, Monica, Stenehjem, Edward, Kharbanda, Anupam B., Han, Jungmi, Spark, Talia L., Irving, Stephanie A., Dixon, Brian E., Zerbo, Ousseny, McEvoy, Charlene E., Rao, Suchitra, Raiyani, Chandni, Sloan-Aagard, Chantel, Patel, Palak, Dascomb, Kristin, Uhlemann, Anne-Catrin, Dunne, Margaret M., Fadel, William F., Lewis, Ned, Barron, Michelle A., Murthy, Kempapura, Nanez, Juan, Griggs, Eric P., Grisel, Nancy, Annavajhala, Medini K., Akinseye, Akintunde, Valvi, Nimish R., Goddard, Kristin, Mamawala, Mufaddal, Arndorfer, Julie, Yang, Duck-Hye, Embí, Peter J., Fireman, Bruce, Ball, Sarah W., Tenforde, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018321/
https://www.ncbi.nlm.nih.gov/pubmed/36920396
http://dx.doi.org/10.1001/jamanetworkopen.2023.2598

Ejemplares similares

Ejemplares similares